Cooper Companies, Inc. (The) (NYSE:COO) – Equities research analysts at Northcoast Research increased their Q3 2017 EPS estimates for Cooper Companies, Inc. (The) in a research note issued to investors on Tuesday. Northcoast Research analyst D. Keiser now forecasts that the medical device company will post earnings per share of $2.65 for the quarter, up from their previous forecast of $2.64. Northcoast Research also issued estimates for Cooper Companies, Inc. (The)’s Q4 2017 earnings at $2.72 EPS, FY2017 earnings at $9.80 EPS, Q1 2018 earnings at $2.44 EPS, Q2 2018 earnings at $2.87 EPS, Q3 2018 earnings at $2.99 EPS, Q4 2018 earnings at $2.92 EPS and FY2018 earnings at $11.20 EPS.

Several other brokerages have also recently issued reports on COO. Zacks Investment Research raised shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 target price for the company in a report on Tuesday. Robert W. Baird restated a “buy” rating and set a $251.00 target price on shares of Cooper Companies, Inc. (The) in a research report on Thursday, August 24th. J P Morgan Chase & Co restated a “neutral” rating and set a $206.00 target price (up from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Jefferies Group LLC set a $250.00 price target on shares of Cooper Companies, Inc. (The) and gave the stock a “buy” rating in a research report on Thursday, August 17th. Finally, Cleveland Research reiterated a “buy” rating on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, August 22nd. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $242.33.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/30/northcoast-research-analysts-raise-earnings-estimates-for-cooper-companies-inc-the-coo.html.

Cooper Companies, Inc. (COO) opened at 246.15 on Wednesday. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39. The company has a market cap of $12.03 billion, a PE ratio of 36.90 and a beta of 0.61. The firm’s 50-day moving average price is $246.40 and its 200-day moving average price is $219.29.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.25 by $0.25. The business had revenue of $522.40 million for the quarter, compared to the consensus estimate of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The firm’s revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.05 EPS.

The business also recently disclosed a semiannual dividend, which was paid on Monday, August 7th. Investors of record on Friday, July 21st were issued a $0.03 dividend. The ex-dividend date was Wednesday, July 19th. This represents a yield of 0.02%. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is currently 0.90%.

In other Cooper Companies, Inc. (The) news, EVP Carol R. Kaufman sold 44,092 shares of Cooper Companies, Inc. (The) stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $242.81, for a total value of $10,705,978.52. Following the completion of the transaction, the executive vice president now directly owns 60,419 shares of the company’s stock, valued at approximately $14,670,337.39. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Stanley Md Zinberg sold 816 shares of Cooper Companies, Inc. (The) stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total value of $198,402.24. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 67,331 shares of company stock worth $16,400,454. 1.60% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the company. Capstone Asset Management Co. bought a new position in shares of Cooper Companies, Inc. (The) during the first quarter worth approximately $269,000. Mn Services Vermogensbeheer B.V. boosted its stake in shares of Cooper Companies, Inc. (The) by 4.4% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,295 shares of the medical device company’s stock worth $242,000 after buying an additional 55 shares in the last quarter. Korea Investment CORP purchased a new stake in shares of Cooper Companies, Inc. (The) during the first quarter worth $1,739,000. Profund Advisors LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 9.1% in the first quarter. Profund Advisors LLC now owns 2,059 shares of the medical device company’s stock worth $412,000 after buying an additional 171 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in shares of Cooper Companies, Inc. (The) by 1.5% in the first quarter. ProShare Advisors LLC now owns 4,896 shares of the medical device company’s stock worth $979,000 after buying an additional 73 shares in the last quarter. 96.09% of the stock is owned by institutional investors and hedge funds.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.